Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 361

1.

[Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].

Dewulf G, Gouin I, Pautas E, Gaussem P, Chaïbi P, Andreux JP, Siguret V.

Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):197-202. French.

PMID:
15047472
[PubMed - indexed for MEDLINE]
2.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
[PubMed - indexed for MEDLINE]
3.

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ.

Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Chinese.

PMID:
19563026
[PubMed - indexed for MEDLINE]
4.

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.

Haematologica. 2006 Dec;91(12):1596-604.

PMID:
17145595
[PubMed - indexed for MEDLINE]
Free Article
5.

Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.

Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.

Leukemia. 1996 Jan;10(1):20-6.

PMID:
8558932
[PubMed - indexed for MEDLINE]
6.

Primary myelodysplastic syndrome: clinical spectrum of 53 cases.

Irfan M, Kakepoto GN, Khursheed M.

J Pak Med Assoc. 1998 Mar;48(3):69-73.

PMID:
9783031
[PubMed - indexed for MEDLINE]
7.

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.

Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.

Leuk Res. 2006 Aug;30(8):971-7. Epub 2006 Jan 19.

PMID:
16423393
[PubMed - indexed for MEDLINE]
8.

[Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].

Rubio-Félix D, Giraldo MP, Perella M, Gimeno J, Franco E, Giralt M.

Sangre (Barc). 1991 Dec;36(6):463-9. Spanish.

PMID:
1812580
[PubMed - indexed for MEDLINE]
9.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

PMID:
19135940
[PubMed - indexed for MEDLINE]
10.

Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.

Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.

Leuk Res. 2004 Jun;28(6):587-94.

PMID:
15120935
[PubMed - indexed for MEDLINE]
11.

Hypoplastic myelodysplastic syndrome.

Nand S, Godwin JE.

Cancer. 1988 Sep 1;62(5):958-64.

PMID:
3409176
[PubMed - indexed for MEDLINE]
12.

Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.

Kyriakou D, Eliopoulos AG, Alexandrakis M, Kalokyri I, Eliopoulos GD.

Haematologia (Budap). 1996;28(1):1-7.

PMID:
9283897
[PubMed - indexed for MEDLINE]
13.

Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.

Vallespi T, Torrabadella M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J.

Br J Haematol. 1985 Sep;61(1):83-92.

PMID:
3863667
[PubMed - indexed for MEDLINE]
14.

The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey.

Demirkan F, Alacacioglu I, Piskin O, Ozsan HG, Akinci B, Ozcan AM, Yavuzsen T, Yuksel E, Undar B.

Leuk Lymphoma. 2007 Jul;48(7):1372-8.

PMID:
17613766
[PubMed - indexed for MEDLINE]
15.

Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes.

Breccia M, Carmosino I, Biondo F, Mancini M, Russo E, Latagliata R, Alimena G.

Leuk Res. 2006 Feb;30(2):178-82. Epub 2005 Aug 15.

PMID:
16102825
[PubMed - indexed for MEDLINE]
16.

Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.

Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.

Acta Paediatr. 2004 Aug;93(8):1015-23. Review.

PMID:
15456186
[PubMed - indexed for MEDLINE]
17.

[Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].

Wei J, Chen Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):305-11. Chinese.

PMID:
18426654
[PubMed - indexed for MEDLINE]
18.

Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.

Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H.

Eur J Haematol. 2009 Mar;82(3):201-7. doi: 10.1111/j.1600-0609.2008.01182.x. Epub 2008 Nov 10.

PMID:
19018862
[PubMed - indexed for MEDLINE]
19.

Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.

Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.

Br J Haematol. 2000 Sep;110(3):584-90.

PMID:
10997968
[PubMed - indexed for MEDLINE]
20.

Myelodysplastic syndromes in the elderly: the role of growth factors in management.

Saba HI.

Leuk Res. 1996 Mar;20(3):203-19. Review.

PMID:
8637215
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk